SEC Form 4 · accession 0001209191-17-033331
BioAmber Inc. · BIOA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kurt W Briner
Director
Period of report
May 11, 2017
Accepted (ET)
May 17, 2017 · 5:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001534287
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.26 | May 11, 2017 | A | 36,000 | A | — | May 11, 2027 | Common Stock | 36,000 | 36,000 | D |
Explanation of responses
- F1These options will vest on a quarterly basis, as follows: 25% will vest on August 11, 2017, 25% will vest on November 11, 2017, 25% will vest on February 11, 2018 and 25% will vest on May 11, 2018.